Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
5 Stocks Under $10 Setting Up to Trade Higher
By Roberto Pedone
Nov 22, 2015 4:05 PM EST
PRESS RELEASES
ContraFect Announces Funding Agreement With The Cystic Fibrosis Foundation
By GlobeNewswire
Aug 25, 2020 7:30 AM EDT
PRESS RELEASES
Contrafect Announces Publication Of Exebacase Phase 2 Study Results In The Journal Of Clinical Investigation
By GlobeNewswire
Jun 17, 2020 7:30 AM EDT
PRESS RELEASES
ContraFect Announces Appointment Of Lishan Aklog, M.D. To Board Of Directors
By GlobeNewswire
Jun 15, 2020 7:30 AM EDT
PRESS RELEASES
ContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer Inc.
By GlobeNewswire
May 26, 2020 7:30 AM EDT
PRESS RELEASES
ContraFect Corporation Prices Approximately $52.5 Million Public Offering Of Common Stock And Warrants
By GlobeNewswire
May 21, 2020 10:59 PM EDT
PRESS RELEASES
ContraFect Corporation Announces Proposed Public Offering Of Common Stock And Warrants
By GlobeNewswire
May 21, 2020 4:09 PM EDT
PRESS RELEASES
ContraFect Announces Dr. Roger J. Pomerantz, Chief Executive Officer And Chairman, Invited As Keynote Speaker And Presenter In Maxim's Infectious Disease Virtual Conference
By GlobeNewswire
Apr 21, 2020 7:00 AM EDT
PRESS RELEASES
ContraFect To Chair And Participate In Virtual Superbugs & Superdrugs 2020 Conference
By GlobeNewswire
Mar 30, 2020 5:00 AM EDT
PRESS RELEASES
ContraFect To Present At FDA Workshop On Advancing Animal Models For Antibacterial Drug Development
By GlobeNewswire
Mar 4, 2020 7:00 AM EST
PRESS RELEASES
ContraFect Announces U.S. FDA Grants Breakthrough Therapy Designation To Exebacase For The Treatment Of Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia, Including Right-Sided Endocarditis
By GlobeNewswire
Feb 24, 2020 7:00 AM EST
PRESS RELEASES
ContraFect Announces One-for-Ten Reverse Stock Split
By GlobeNewswire
Feb 4, 2020 7:00 AM EST
PRESS RELEASES
ContraFect Appoints Jane E. Ambler, Ph.D. As Vice President Of Clinical Microbiology
By GlobeNewswire
Feb 3, 2020 7:00 AM EST
PRESS RELEASES
ContraFect Announces Oral Presentations At The 30th European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID)
By GlobeNewswire
Jan 27, 2020 7:00 AM EST
OPINION
5 Stocks Under $10 Setting Up to Trade Higher
By Roberto Pedone
Nov 22, 2015 4:05 PM EST
